Adage Capital Partners Gp, L.L.C. Immunome Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $51.6 Billion
- Q1 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Immunome Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 775,000 shares of IMNM stock, worth $8.46 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
775,000
Previous 500,000
55.0%
Holding current value
$8.46 Million
Previous $5.13 Million
1.66%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding IMNM
# of Institutions
150Shares Held
66.5MCall Options Held
47.3KPut Options Held
4.31M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.55MShares$82.4 Million0.03% of portfolio
-
Redmile Group, LLC San Francisco, CA5.36MShares$58.5 Million3.79% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.36MShares$47.6 Million0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.31MShares$47 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$44.5 Million2.16% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $132M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...